ConductScience.org, home

Paper42908035PubMed

Multiomics, multi-species profiling, and animal validation identify mitoxyperilysis as a conserved therapeutic target in metabolic dysfunction-associated steatohepatitis.

Liu H and 8 others. Biol Direct, 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Multiomics, multi-species profiling, and animal validation identify mitoxyperilysis as a conserved therapeutic target in metabolic dysfunction-associated steatohepatitis. Papers, record 42908035. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42908035

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multiomics, multi-species profiling, and animal validation identify mitoxyperilysis as a conserved therapeutic target in metabolic dysfunction-associated steatohepatitis.
Journal
Biol Direct
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-24

Source PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu HHanjiehttps://orcid.org/0009-0005-6495-4705
2Qi CCong
3Lu RRuixia
4An CChuan
5Wang YYangzhiyuan
6Li SShumiao
7Zhu RRui
8Feng XXingzhong
9Gao HHuijuanhttps://orcid.org/0000-0002-2606-848X

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Fatty LiverMajor topic
Metabolic DiseasesMajor topic
Animals
Mice
Humans
Multiomics
Male
Transcriptome
Disease Models, Animal

Source PubMed

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129,914,354Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics.BMC Genomics2018https://conductscience.org/library/papers/29914354PubMed
231,891,606Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).PLoS One2019https://conductscience.org/library/papers/31891606PubMed
338,036,728Mitochondrial nucleic acids in innate immunity and beyond.Exp Mol Med2023https://conductscience.org/library/papers/38036728PubMed
439,838,105Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer.Nat Immunol2025https://conductscience.org/library/papers/39838105PubMed
537,939,656The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease.Cell Metab2023https://conductscience.org/library/papers/37939656PubMed
636,052,866Hepatic gene expression and functional changes associated with nonalcoholic steatohepatitis.Mol Med Rep2022https://conductscience.org/library/papers/36052866PubMed
738,908,436Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation.J Hepatol2024https://conductscience.org/library/papers/38908436PubMed
834,050,922Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship.Eur J Clin Invest2022https://conductscience.org/library/papers/34050922PubMed
939,244,571Targeting cell death in NAFLD: mechanisms and targeted therapies.Cell Death Discov2024https://conductscience.org/library/papers/39244571PubMed
1037,756,381Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis.Sci Transl Med2023https://conductscience.org/library/papers/37756381PubMed
1141,286,103Spatially resolved multi-omics of human metabolic dysfunction-associated steatotic liver disease.Nat Genet2025https://conductscience.org/library/papers/41286103PubMed
1240,568,942MEBOCOST maps metabolite-mediated intercellular communications using single-cell RNA-seq.Nucleic Acids Res2025https://conductscience.org/library/papers/40568942PubMed
1342,088,521Integrated transcriptomic and single cell analysis combined with artificial neural network identifies a robust gene signature for early discrimination of MASL and MASH.Front Immunol2026https://conductscience.org/library/papers/42088521PubMed
1438,438,948CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis.J Hepatol2024https://conductscience.org/library/papers/38438948PubMed
1541,317,732Innate immune and metabolic signals induce mitochondria-dependent membrane lysis via mitoxyperiosis.Cell2025https://conductscience.org/library/papers/41317732PubMed
1635,501,558Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease.Curr Obes Rep2022https://conductscience.org/library/papers/35501558PubMed
1741,096,980Obesity-Driven Metabolic Disorders: The Interplay of Inflammation and Mitochondrial Dysfunction.Int J Mol Sci2025https://conductscience.org/library/papers/41096980PubMed
1831,974,247Single-cell transcriptional diversity is a hallmark of developmental potential.Science2020https://conductscience.org/library/papers/31974247PubMed
1931,992,752Biomarker discovery for chronic liver diseases by multi-omics - a preclinical case study.Sci Rep2020https://conductscience.org/library/papers/31992752PubMed
2027,942,596Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis.JCI Insight2016https://conductscience.org/library/papers/27942596PubMed

See all 38 references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42908035

GET https://conductscience.org/api/papers/v1/42908035/references?page=2